
        <html>
        <head>
            <style>
                body { font-family: Arial, sans-serif; line-height: 1.6; margin: 20px; }
                h3 { color: #333; }
                .question { margin-bottom: 15px; }
                .options { margin-left: 20px; margin-bottom: 10px; }
                .solution { background: #f8f9fa; padding: 10px; border-left: 4px solid #007bff; }
                .credits { text-align: center; margin-top: 20px; font-size: 18px; }
                .rainbow-text { 
                    background: linear-gradient(90deg, red, orange, yellow, green, blue, indigo, violet); 
                    -webkit-background-clip: text; 
                    color: transparent; 
                    font-weight: bold; 
                }
            </style>
        </head>
        <body>
        
            <div class="question">
                <h3>Question No: 1</h3>
                <p><b>A patient with multiple gastric ulcers was diagnosed with Zollinger-Ellison syndrome. What is the drug of choice for the treatment?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. H2 blockers</li><li>2. Proton pump inhibitors</li><li>3. Prostaglandin analogue</li><li>4. Sucralfate</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Zollinger-Ellison syndrome is a condition of hypersecretory state due to gastrinoma, in which a rare tumor secretes gastrin, which makes it difficult to heal gastric/duodenal ulcers. </li><li>High-dose PPI is indicated as the drug of choice for controlling symptoms and complete symptomatic relief and healing of ulcers can be achieved by PPI which lowers the daily acid output to a normal limit.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 2</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong><strong>A patient present with the following vital signs:</strong></strong></p>
<ul>
<li>Blood Pressure: 178/120</li>
<li>Pulse: 112</li>
<li>Respiratory Rate: 28</li>
<li>Oxygen Saturation: 98%</li>
<li>Temperature: 99.0&deg;F</li>
</ul>
<p>The patient reports a headache and blurred vision. Which of the following is the drug of choice for this condition?</p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Metoprolol 100 mg orally (P.O.)</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Clonidine 0.3 mg orally (P.O.)</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Metoprolol 5 mg intravenously (IV)</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Paracetamol 650 mg orally (P.O.)</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A significant rise in blood pressure accompanied by clinical symptoms such as headache and blurred vision is indicative of a <strong>hypertensive emergency</strong>.</p>
<p><strong>Management of Hypertensive Emergency:</strong></p>
<p>The <strong>drugs of choice</strong> are intravenous <strong>calcium channel blockers (CCBs)</strong> such as <strong>Nicardipine</strong> and <strong>Clevidipine</strong>. If CCBs are not available or not an option, intravenous <strong>beta-blockers</strong> like <strong>Labetalol</strong>, <strong>Esmolol</strong>, or <strong>Metoprolol</strong> can be used as alternatives.</p>
<p><strong>Hypertensive Urgency:</strong></p>
<p>Hypertensive urgency is characterized by <strong>systolic blood pressure (SBP) &ge; 220 mmHg</strong> and/or <strong>diastolic blood pressure (DBP) &ge; 125 mmHg</strong> without evidence of end-organ damage.</p>
<ul>
<li>The <strong>drug of choice</strong> for hypertensive urgency is <strong>oral Clonidine</strong>.</li>
<li>Other medications that may be used include <strong>Enalapril</strong> and <strong>Nifedipine</strong>.</li>
</ul>
<p><strong>Explanation:</strong> Metoprolol, given intravenously, is the optimal choice in a hypertensive emergency because it rapidly reduces both blood pressure and heart rate. This addresses the hypertensive crisis effectively and promptly.</p>
<ul>
<li><strong>Correct:</strong> This is the most appropriate intervention for immediate treatment.</li>
</ul>
<p><strong>Explanations:</strong></p>
<p><strong>Option A: Metoprolol 100 mg orally (P.O.)</strong></p>
<ul>
<li><strong>Explanation:</strong> Although oral metoprolol can lower blood pressure and heart rate, it takes approximately 30 minutes to act. In a hypertensive crisis, immediate action is necessary, and IV medication is preferred for rapid effect.</li>
<li><strong>Incorrect:</strong> Oral administration is not appropriate for a hypertensive emergency due to delayed onset.</li>
</ul>
<p><strong>Option B: Clonidine 0.3 mg orally (P.O.)</strong></p>
<ul>
<li><strong>Explanation:</strong> Clonidine is effective for managing hypertensive emergencies but does not specifically address the elevated heart rate in this case. Additionally, oral clonidine would take longer to act compared to IV antihypertensives.</li>
<li><strong>Incorrect:</strong> Clonidine is not the most suitable choice due to the patient's tachycardia and the delayed onset of the oral route.</li>
</ul>
<p><strong>Option D: Paracetamol 650 mg orally (P.O.)</strong></p>
<ul>
<li><strong>Explanation:</strong> The patient&rsquo;s headache is a symptom of elevated blood pressure, which will improve as the hypertension is treated. Paracetamol is unnecessary for addressing the underlying cause of the headache.</li>
<li><strong>Incorrect:</strong> Treating the headache symptomatically without addressing the hypertensive crisis is inadequate care.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 3</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The microscopy of fecal sample of a patient showed presence of Ascaris lumbricoides eggs. This condition can most effectively be treated with which of the following drugs?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Metronidazole</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Mebendazole</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Albendazole</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pyrantel pamoate</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li><strong>Roundworm infestation</strong> is most effectively treated with <strong>albendazole</strong>. It is considered as the <strong>drug of choice</strong> for the treatment of roundworm (Ascaris lumbricoides) infestation.</li>
<li>Albendazole is considered as the <strong>drug of choice</strong> for treatment of infestation by:</li>
<li>Whipworm - <em>Trichuris trichura</em> causing trichuriasis</li>
<li>Hookworm - <em>Ancylostoma duodenale</em></li>
<li>Roundworm - <em>Ascaris lumbricoides</em></li>
<li>Dog tapeworm - <em>Echinococcus granulosus</em> causing hydatid disease</li>
<li>Albendazole is administered as a <strong>single oral 400-mg dose</strong> to adults and children more than 2 years of age. Safety is not established for children less than 2 years. However, according to WHO, if the benefit outweighs the risk, albendazole at 200 mg can be given to children between the ages of 1-2 years.</li>
</ul>
<p><strong>Table: Anthelminthic Drugs </strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 19.964%;" width="113">
<p><strong>Organism</strong></p>
</td>
<td style="width: 51.7986%;" width="425">
<p><strong>Disease</strong></p>
</td>
<td style="width: 28.2374%;" width="170">
<p><strong>Drug of Choice</strong></p>
</td>
</tr>
<tr>
<td style="width: 19.964%;" rowspan="4" width="113">
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>Nematodes</p>
</td>
<td style="width: 51.7986%;" width="425">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Soil transmitted helminths</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Round worm (Ascaris lumbricoides)</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hook worm (Necator Americans, Ancylostoma duodenale)</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Whip worm (Trichuris trichuria)&nbsp;</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Trichinella spiralis</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enterovirus vermicularis</p>
</td>
<td style="width: 28.2374%;" width="170">
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>Albendazole</p>
</td>
</tr>
<tr>
<td style="width: 51.7986%;" width="425">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Thread worm (Strongyloides stercoralis)</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Onchocerca Volvulus</p>
</td>
<td style="width: 28.2374%;" width="170">
<p>Ivermectin</p>
</td>
</tr>
<tr>
<td style="width: 51.7986%;" width="425">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Filariasis</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loa Loa</p>
</td>
<td style="width: 28.2374%;" width="170">
<p>Diethyl Carbamazine (DEC)</p>
</td>
</tr>
<tr>
<td style="width: 51.7986%;" width="425">
<p>Dracunculiasis</p>
</td>
<td style="width: 28.2374%;" width="170">
<p>Metronidazole</p>
</td>
</tr>
<tr>
<td style="width: 19.964%;" rowspan="2" width="113">
<p>Cestodes</p>
</td>
<td style="width: 51.7986%;" width="425">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Neurocysticercosis</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Echinococcus</p>
</td>
<td style="width: 28.2374%;" width="170">
<p>Albendazole</p>
</td>
</tr>
<tr>
<td style="width: 51.7986%;" width="425">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Intestinal T. solium</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; T. saginata</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. nana</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; D. latum</p>
</td>
<td style="width: 28.2374%;" width="170">
<p>Praziquantel</p>
</td>
</tr>
<tr>
<td style="width: 19.964%;" rowspan="2" width="113">
<p>&nbsp;</p>
<p>Trematodes</p>
</td>
<td style="width: 51.7986%;" width="425">
<p><strong>Liver Fluke (Fasciola hepatics)</strong></p>
</td>
<td style="width: 28.2374%;" width="170">
<p><strong>Triclabendazole</strong></p>
</td>
</tr>
<tr>
<td style="width: 51.7986%;" width="425">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lung fluke (Paragoimus)</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Schistosoma</p>
</td>
<td style="width: 28.2374%;" width="170">
<p>Praziquantel</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 4</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A diabetic patient is diagnosed with hypertension during his annual health check-up. What is the treatment of choice?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Chlorthalidone</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Carvedilol</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Captopril</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Nifedipine</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li><strong>ACE inhibitors</strong> such as <strong>captopril</strong> or ARBs can be considered as a <strong>treatment of choice</strong> in <strong>hypertensive patients with diabetes</strong> because of the renoprotective action. It benefits diabetic patients by <strong>reducing </strong>the <strong>risk </strong>of occurrence and progression of diabetic <strong> </strong></li>
<li>They are also recommended in patients with CKD irrespective of diabetes status as they can delay the progression of nephropathy.</li>
<li><strong>Option A: Thiazide</strong> diuretics <strong>worsen</strong> glycemic control and are not preferred in diabetic patients.</li>
<li><strong>Option B: Beta-blockers</strong>, especially non-selective blockers, <strong>worsen </strong>glycemic control.</li>
<li><strong>Option D:</strong> <strong>Calcium channel blockers</strong> have a <strong>neutral effect</strong> on glycemic control and can be used in diabetes if ACE inhibitors or ARBs cannot be given.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 5</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A 4-month-old boy was brought to the ER with recurrent seizures. His mother informs you that he is receiving isoniazid prophylaxis as she was diagnosed with TB during pregnancy. ABG revealed a high anion gap metabolic acidosis. What would be the mainstay of treatment?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Benzodiazepines</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Barbiturates</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pyridoxine</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Thiamine</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>The given clinical scenario is suggestive of <strong>isoniazid overdose</strong> for which the mainstay of treatment is <strong>intravenous pyridoxine. </strong></li>
<li><strong>Isoniazid</strong> overdose results in decreased pyridoxine availability to neurons. This <strong>decreases</strong> the levels of <strong>GABA,</strong> which in turn lowers the seizure threshold. B<strong>enzodiazepines </strong>can be used to control</li>
<li>Prolonged treatment with isoniazid leads to the <strong>deficiency of pyridoxine</strong> which can lead to <strong>peripheral neuropathy</strong> and other neurological manifestations like ataxia, paresthesia, and numbness.</li>
</ul>
<p><strong>Clinical triad of isoniazid overdose: </strong></p>
<ul>
<li>Seizures refractory to treatment with phenytoin and barbiturates</li>
<li>High anion gap metabolic acidosis (HAGMA) resistant to treatment with sodium bicarbonate</li>
<li>Coma</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 6</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>What is the drug of choice in the treatment of infantile spasms?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>ACTH</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Phenobarbitone</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Carbamazepine</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Vigabatrin</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>The drug of choice in the treatment of <strong>infantile spasms or West syndrome</strong> is <strong>adrenocorticotropic hormone</strong> (ACTH.)</li>
<li>The mechanism of action of ACTH or glucocorticoids is unknown but may involve a reduction in inflammatory processes.</li>
<li><strong>Vigabatrin </strong>is used if the spasms are associated with <strong>tuberous sclerosis</strong>.</li>
<li>Other antiseizure medications that may be helpful are valproate, topiramate, zonisamide, or benzodiazepines.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 7</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>What is the most appropriate treatment for a patient with severe digoxin toxicity?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Potassium supplements</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Propafenone</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Quinidine</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Fab fragments of digoxin antibodies</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>The most appropriate treatment for severe digoxin toxicity is purified <strong>Fab fragments of digitalis antibodies</strong> (Digibind).</li>
<li>It <strong>neutralizes the digoxin action</strong> and its dosage is based upon the total dose of digoxin ingested.</li>
<li><strong>Option A: KCI infusion</strong> is indicated in <strong>mild toxicity</strong> as hyperkalemia decreases the binding of digoxin by dephosphorylating Na/K ATPase pump. In acute severe poisoning, potassium is not indicated as it may already be high in plasma. Potassium is also not indicated when a higher degree of AV block is present.</li>
<li><strong>Options B and C: </strong>Quinidine and propafenone are not indicated in arrhythmias caused by digoxin. &nbsp;&nbsp;</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 8</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Inhaled nitric oxide (iNO) is used for?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Persistent pulmonary hypertension of newborn</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Unstable angina</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Obstructive sleep apnea</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Erectile dysfunction</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Inhaled nitric oxide(iNO) is used for <strong>persistent pulmonary hypertension in newborns</strong>. (Option A)</li>
<li><strong>Inhaled NO</strong> selectively <strong>dilates </strong>the pulmonary vasculature, hence used in diseases associated with increased pulmonary vascular resistance. Inhaled NO is an FDA-approved drug for persistent pulmonary hypertension in the newborn.</li>
<li>Inhaled NO can also be used during <strong>cardiac catheterization</strong> to evaluate the <strong>pulmonary vasodilating capacity</strong> of patients with <strong>heart failure</strong> and infants with <strong>congenital heart disease</strong>. Another use of inhaled NO is to determine the <strong>diffusion capacity (DL</strong>) across the alveolar-capillary membrane. It is more effective than CO<sub>2</sub> because of its greater affinity for hemoglobin and its higher water solubility at body temperature.</li>
<li>NO is produced from the nasal passages and the lungs of normal human subjects and can be detected in exhaled gas. The measurement of fractional <strong>exhaled NO</strong> is a <strong>non-invasive marker</strong> for airway inflammation in the assessment of respiratory tract diseases, including <strong>asthma, respiratory tract infection</strong>, and <strong>chronic lung disease.</strong></li>
<li>Inhaled NO is administered at <strong>low concentrations (0.1-50 ppm)</strong> since high concentrations of 50 to 100 ppm can cause significant <strong>methemoglobinemia</strong> that can cause death.</li>
</ul>
<p><strong>Other options:</strong></p>
<ul>
<li><strong>Option B: Unstable angina</strong> is treated by <strong>anti-platelet drugs</strong> such as aspirin and clopidogrel, and anticoagulants such as heparin.</li>
<li><strong>Option C: Obstructive sleep apnoea</strong> is mainly treated by using a <strong>BiPAP machine</strong> during sleep and <strong>CNS stimulants</strong> such as <strong>armodafinil f</strong>or <strong>daytime sleepiness</strong> associated with the condition.</li>
<li><strong>Option D: Erectile dysfunction</strong> is treated by <strong>PDE5 inhibitors</strong> such as <strong>sildenafil,</strong> tadalafil, etc.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 9</h3>
                <p><b>What is the drug of choice for diphtheria carrier state?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Amoxicillin</li><li>2. Erythromycin</li><li>3. Rifampicin</li><li>4. Tetracycline</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The drug of choice for diphtheria carrier state is erythromycin.</li><li>Erythromycin for 7 days is very effective for eradicating the diphtheria carrier state or acute infections.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 10</h3>
                <p><b>Which of the following drugs can be used in diabetic neuropathy, post herpetic neuralgia and spinal cord injury?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Amitriptyline</li><li>2. Phenytoin</li><li>3. Carbamazepine</li><li>4. Pregabalin</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Pregabalin can be used for diabetic neuropathy, post herpetic neuralgia and spinal cord injury. Although amitriptyline can also be used for these conditions, pregabalin is found to be recommended over amitriptyline considering safety and efficacy and hence is the best option.</li><li>Pregabalin is an anti-epileptic drug. Its analgesic effect is mediated by binding to α2δ, a protein that is a subunit of voltage-gated calcium channels and causes a decrease in glutamate release at excitatory synapses. Decreased neurotransmitter release is associated with reduced neuronal hyperexcitability. It is used in the management of neuropathic pain associated with diabetic peripheral neuropathy, spinal cord injury or post herpetic neuralgia.</li><li>Currently, only duloxetine and pregabalin are approved by the U.S. Food and Drug Administration and the European Medicines Agency to treat painful diabetic neuropathy. Diabetic Neuropathy is the most common cause of peripheral neuropathy in developed countries. Risk factors include long-standing, poorly controlled DM and the presence of retinopathy and nephropathy.</li><li>Side effects of pregabalin include sedation and peripheral edema. </li></ul><p><b>Other options:</b><ul ><li><b>Option A:</b> Tricyclic antidepressants (TCAs) such as amitriptyline are used in the treatment of several pain conditions such as diabetic neuropathy, post herpetic neuralgia and following spinal cord injury. Their mechanism of action is inhibition of norepinephrine and serotonin reuptake. Although both pregabalin and amitriptyline are among the first line drugs for neuropathic pain, amitriptyline would be the next best option in this question, owing to its side effect profile and good yet controversial efficacy in pain control. It is a non FDA approved drug for diabetic neuropathy (off label indication). Side effects associated with amitriptyline include anticholinergic side effects (dry mouth, tachycardia, hyperthermia), cardiac effects (arrhythmias) and sedation. </li><li><b>Option B:</b> Phenytoin is an antiepileptic drug that is not used in the treatment of pain.</li><li><b>Option C:</b> Carbamazepine is an iminostilbine derivative. It blocks voltage-activated sodium channels, slowing their rate of recovery and limiting the repetitive firing of action potentials. It is used in the treatment of generalized, focal-to-bilateral and idiopathic tonic-clonic seizures, focal seizures, neuropathic pain associated with trigeminal and glossopharyngeal neuralgias.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 11</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Match the following bacteria with the drug of choice used for each.</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 46.0432%;" width="208">
<p><strong>Column-A</strong></p>
</td>
<td style="width: 53.9568%;" width="246">
<p><strong>Column-B</strong></p>
</td>
</tr>
<tr>
<td style="width: 46.0432%;" width="208">
<p>A.&nbsp;&nbsp; Bacteroides</p>
<p>B.&nbsp;&nbsp;&nbsp; MRSA</p>
<p>C.&nbsp;&nbsp;&nbsp; Hemophilus</p>
<p>D.&nbsp;&nbsp; Klebsiella</p>
</td>
<td style="width: 53.9568%;" width="246">
<p>1)&nbsp;&nbsp;&nbsp; Vancomycin</p>
<p>2)&nbsp;&nbsp;&nbsp; Metronidazole</p>
<p>3)&nbsp;&nbsp;&nbsp; Meropenem</p>
<p>4)&nbsp;&nbsp;&nbsp; Penicillin</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-1, B-3, C-4, D-2</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-2, B-1, C-4, D-3</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-3, B-4, C-1, D-2</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A-4, B-1, C-2, D-3</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li><strong>Vancomycin </strong>is Drug of Choice for <strong>Methicillin-Resistant Staphylococcus aureus (MRSA)</strong> (should be used only if other drugs are resistant).</li>
<li><strong>Metronidazole</strong> is the drug of choice for anaerobic infections caused by</li>
<li>Uses of metronidazole include:
<ul>
<li>Giardiasis</li>
<li>Trichomoniasis</li>
<li>Amoebiasis</li>
<li>Bacterial vaginosis</li>
<li>treatment of pseudomembranous colitis.</li>
</ul>
</li>
<li><strong>Meropenem</strong> is used in infections caused by ESBL producing bacteria like</li>
<li>Carbapenems are not hydrolyzed by ESBL (extended-spectrum beta-lactamases). Therefore, carbapenems like imipenem, meropenem, ertapenem are resistant to hydrolysis by extended-spectrum beta-lactamases and are indicated in the treatment of infections caused by ESBL producing bacteria. ESBL is most prevalent among gram-negative organisms like <strong><em>Klebsiella and E. coli.</em></strong></li>
<li><strong>Penicillins </strong>like amoxicillin, ampicillin can be used in <strong><em>H. influenzae</em> infections</strong>.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 12</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following is the drug of choice for the immediate management of a patient with paroxysmal supraventricular tachycardia?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Verapamil</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Diltiazem</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Digoxin</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Adenosine</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>The drug of choice for the termination of <strong>PSVT</strong> is <strong>adenosine.</strong></p>
<p>Drugs used for s<strong>upraventricular</strong> arrhythmias are:</p>
<ul>
<li>Adenosine</li>
<li>Verapamil</li>
<li>Diltiazem</li>
<li>Digoxin</li>
</ul>
<p>Drugs used for <strong>ventricular arrhythmias</strong> are:</p>
<ul>
<li>Lidocaine</li>
<li>Mexiletine</li>
</ul>
<p>Drugs used in<strong> both</strong> conditions are:</p>
<ul>
<li>Amiodarone</li>
<li>Beta-blockers</li>
<li>Class 1a / 1c anti-arrhythmics</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 13</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A 23-year-old primiparous woman presented with features suggestive of thyrotoxicosis, at 7 weeks of gestation. Which of the following is the drug of choice for the treatment of her condition?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Methimazole</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Carbimazole</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Propylthiouracil</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Radioactive iodine</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>The <strong>drug of choice</strong> for the treatment of thyrotoxicosis during the <strong>first trimester</strong> of pregnancy is <strong>propylthiouracil (PTU).</strong> It is because it has lower teratogenic effects than carbimazole or methimazole.</li>
<li><strong>Carbimazole </strong>and <strong>methimazole</strong> are associated with teratogenic effects such as:
<ul>
<li>Aplasia cutis congenita</li>
<li>Choanal atresia</li>
<li>Tracheoesophageal fistula</li>
<li>Fetal goiter</li>
</ul>
</li>
<li>However, propylthiouracil use is limited to the first trimester due to the <strong>risk of hepatotoxicity</strong>. It is replaced with carbimazole or methimazole in the 2<sup>nd</sup> and 3<sup>rd</sup> trimesters of the pregnancy.</li>
<li>The lowest effective antithyroid drug dose should be used throughout gestation. This is to <strong>maintain</strong> the <strong>maternal</strong> serum-<strong>free T4 level</strong> in the <strong>upper limit</strong> of the <strong>non-pregnant normal</strong> reference range.</li>
<li><strong>Radioiodine therapy</strong> is <strong>contraindicated</strong> during pregnancy and lactation.</li>
</ul>
<ul>
<li><strong>Drug of choice for hyperthyroidism/thyrotoxicosis in pregnancy</strong></li>
<li>In the 1<sup>st</sup> trimester: <strong>Propylthiouracil</strong></li>
<li>In the 2<sup>nd</sup> and 3<sup>rd</sup> trimester: <strong>Methimazole</strong></li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 14</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following is the drug of choice for scrub typhus?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Doxycycline</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Azithromycin</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Chloramphenicol</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Ciprofloxacin</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li><strong>Doxycycline </strong>is the drug of choice for scrub typhus.</li>
<li>Azithromycin, chloramphenicol, or rifampin can be administered as alternatives in patients allergic to doxycycline and in pregnancy.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 15</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>An elderly patient is brought to the emergency room in a drowsy state after taking an overdose of his sleeping pills. His medical history includes insomnia for which he was on alprazolam. Which of the following medication will you administer to this patient?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Naloxone</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Flumazenil</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Naltrexone</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Nalmefene</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>The patient is presenting with <strong>benzodiazepine</strong> (alprazolam) <strong> Flumazenil</strong> is the drug of choice for this patient. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li><strong>Flumazenil </strong>is a <strong>competitive antagonist</strong> at the benzodiazepine binding site of the GABA<sub>A</sub> It antagonizes both the agonist (benzodiazepines) and inverse-agonist (beta-carbolines) of this receptor. &nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>It is primarily indicated for the management of benzodiazepine overdose and the reversal of benzodiazepine anesthesia. &nbsp;&nbsp;&nbsp;</li>
</ul>
<p><strong>Other options: &nbsp;&nbsp;</strong></p>
<ul>
<li><strong>Option A: Naloxone</strong> is an opioid antagonist used in the management of <strong>opioid overdose. &nbsp;&nbsp;&nbsp;&nbsp;</strong></li>
<li><strong>Option C: Naltrexone</strong>, another opioid antagonist, is used in the management of <strong>alcohol dependence</strong>, prevention of relapse in <strong>opioid deaddiction</strong> after detoxification, and <strong>weight management</strong>. It might cause liver failure.</li>
<li><strong>Option D: Nalmefene</strong> is a pure opioid antagonist with higher potency than naloxone. It is used for the treatment of opioid toxicity and substance abuse.</li>
</ul>
<p><strong>Pure opioid antagonists </strong></p>
<ul>
<li><strong>Naloxone: S</strong>hort-acting opioid antagonist with duration of action of 1-2 hours. Used in opioid overdose and respiratory depression in newborns due to perinatal opioid use.</li>
<li><strong>Naltrexone:</strong> Long-acting opioid antagonist with effects lasting till 48 hours. Used for prevention of relapse in opioid addiction treatment. It is associated with hepatotoxicity. It does not suppress craving in opioid addiction but suppresses craving in chronic alcoholics.</li>
<li><strong>Nalmefene:</strong> Long-acting opioid antagonist with a half-life of 8-10 hours administered intravenously. Used in opioid overdose like naloxone.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 16</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong><strong>A 10-year-old child is brought to the OPD with a history of vacant stares lasting for about half a minute. The EEG shows a characteristic 3 Hz spike and wave pattern. Which of the following drugs can be used for this condition?</strong></strong></p>
<ol>
<li>Carbamazepine</li>
<li>Valproate</li>
<li>Ethosuximide</li>
<li>Gabapentin</li>
<li>Pregabalin</li>
</ol>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1, 2 and 5</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>2 and 3</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>2 only</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>3, 4 and 5</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>The given clinical scenario is suggestive of <strong>absence seizures. Ethosuximide</strong> and<strong> valproate</strong> are the first-line drugs in this condition.</li>
<li>Absence seizures are characterized by <strong>sudden,</strong> brief <strong>lapses </strong>of <strong>consciousness</strong> without loss of postural control. There is no postictal confusion. The following subtle motor signs may accompany the episodes.</li>
<li>Rapid blinking of the eyelids</li>
<li>Chewing movements</li>
<li>Small-amplitude clonic movements of the hands</li>
<li><strong>Hyperventilation</strong> has a tendency to <strong>provoke</strong> absence seizures. First-line drugs include:</li>
<li>Typical absence seizures: Ethosuximide (<strong>drug of choice</strong>), valproate, lamotrigine</li>
<li>Atypical absence seizures: Valproate</li>
</ul>
<p><strong>Table: First-line Agents in Different Types of Seizures</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 35.4317%;" width="180">
<p><strong>Type of seizure</strong></p>
</td>
<td style="width: 64.5683%;" width="340">
<p><strong>1<sup>st</sup>-line antiepileptic drugs</strong></p>
</td>
</tr>
<tr>
<td style="width: 35.4317%;" width="180">
<p>Focal seizures</p>
</td>
<td style="width: 64.5683%;" width="340">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Carbamazepine</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Oxcarbazepine</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lamotrigine</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Levetiracetam</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Phenytoin</p>
</td>
</tr>
<tr>
<td style="width: 35.4317%;" width="180">
<p>GTCS</p>
</td>
<td style="width: 64.5683%;" width="340">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sodium valproate</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Levetiracetam</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lamotrigine</p>
</td>
</tr>
<tr>
<td style="width: 35.4317%;" width="180">
<p>Typical absence seizures</p>
</td>
<td style="width: 64.5683%;" width="340">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ethosuximide (<strong>drug of choice</strong>)</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sodium valproate</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lamotrigine</p>
<p>&nbsp;</p>
</td>
</tr>
<tr>
<td style="width: 35.4317%;" width="180">
<p>Atypical absence seizures</p>
</td>
<td style="width: 64.5683%;" width="340">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sodium valproate</p>
</td>
</tr>
<tr>
<td style="width: 35.4317%;" width="180">
<p>Myoclonic seizures</p>
</td>
<td style="width: 64.5683%;" width="340">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Sodium valproate</strong> (drug of choice)</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lamotrigine</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Topiramate</p>
</td>
</tr>
</tbody>
</table>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 17</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The drug of choice in anaphylactic shock is:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Adrenaline 0.5 mg 1/1000 IM</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Adrenaline 1 mg 1/10000 IV</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Atropine 3 mg</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Adenosine 6 mg followed by 12 mg IV</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li><strong>Adrenaline 0.5 mg 1/1000 by intramuscular route (IM)</strong> is the <strong>drug of choice</strong> for treatment of anaphylactic shock. Hence it is the answer here.</li>
<li>In case the <strong>patient develops life threatening condition, adrenaline 0.25 mg IV</strong> is given.</li>
</ul>
<p><strong>Note:</strong> This is a controversial question. The following inference from journal may help to clarify the concept.</p>
<ul>
<li>As <strong>vasodilatation</strong> is the main pathological change <strong>early</strong> in anaphylaxis, this enables the <strong>subcutaneous or intramuscular absorption</strong> of adrenaline to be rapid and effective.</li>
<li>Thus, when the disease is <strong>treated early</strong> and is progressing slowly, or venous access is difficult or the patient is unmonitored, <strong>intramuscular adrenaline has advantages</strong> in terms of safety and is usually effective.</li>
<li>Later, <strong>when intravascular volume is depleted and shock occurs with a life threatening situation</strong>, or there is severe dyspnoea or airway compromise, the <strong>intravenous route is necessary to achieve optimal absorption.</strong></li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 18</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A 24-year-old with schizophrenia has not responded to adequate treatment with two different antipsychotics. Which of the following would be the drug of choice for his condition?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Olanzapine</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Clozapine</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Risperidone</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Paliperidone</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>The <strong>drug of choice</strong> for treatment-resistant schizophrenia is</li>
<li><strong>Treatment-resistant schizophrenia</strong> is the <strong>lack of response</strong> to <strong>two different antipsychotics</strong> given at adequate dosages for a minimum duration of <strong>4-6 weeks</strong>. If patients demonstrate even a mild amount of improvement during this period, it may be reasonable to wait before changing the medication, since patients may improve at a steady rate for 3-6 months.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 19</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A patient diagnosed with ulcerative colitis presents with 2-3 episodes of bloody stools per day. What should be given to manage this patient?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Budesonide</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Azathioprine</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>6-mercaptopurine</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>5-aminosalicylic acid</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li><strong>5-aminosalicylic acid</strong> is effective in <strong>inducing and maintaining remission</strong> and is considered to be the <strong>first line agents</strong> for <strong>mild to moderate ulcerative colitis</strong>, seen in this patient with <strong>2-3 bloody stools per day.</strong></li>
<li><strong>Treatment</strong> of <strong>ulcerative colitis</strong> differs based on the <strong>severity of the disease</strong> and involves medical and surgical management. Patients with <strong>mild to moderate</strong> disease are treated with <strong>topical or systemic 5-aminosalicylate drugs</strong> such as <strong>Salazopyrine/Sulfasalazine</strong> and <strong>Mesalamine (5 ASA)</strong> which are <strong>first-line therapy. </strong></li>
<li><strong>Glucocorticoids</strong> (option A), i<strong>mmunosuppressants</strong>, and <strong>biologics</strong> are effective in patients with <strong>moderate to severe disease.</strong></li>
<li><strong>Azathioprine and cyclosporin</strong> are used as <strong>steroid-sparing agents</strong>.</li>
<li><strong>Anti-TNF alpha inhibitors</strong> (infliximab, adalimumab) can be used as <strong>anti-inflammatories.</strong></li>
<li><strong>Surgery</strong> is recommended for patients who <strong>do not improve after medical treatment</strong> or <strong>with toxic megacolon, and perforation.</strong> Indications for <strong>elective surgery</strong> include failure of medical therapy, growth retardation, extraintestinal disease, and malignant change.</li>
<li><strong>Option B and C: Azathioprine and 6-mercaptopurine</strong> are not first line agents for ulcerative colitis. &nbsp;&nbsp;&nbsp;</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 20</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Pegloticase is used in management of:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Chronic gout</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Rheumatoid arthritis</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Psoriatric arthritis</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Calcium pyrophosphate dihydrate crystal deposition (CPPD)</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li><strong>Pegloticase</strong> is used in the treatment of <strong>chronic gout.</strong></li>
<li>Pegloticase is a <strong>pegylated uricase</strong> (urate oxidase). It catalyzes the enzymatic oxidation of <strong>uric acid into allantoin,</strong> which is a more soluble and inactive metabolite.</li>
<li>It is used in the treatment of <strong>severe, refractory chronic gout</strong> or in cases where other urate-lowering therapies are contraindicated.</li>
</ul>
</body>
</html></li></ul></div></div>
        <div class="credits">
            <p class="rainbow-text">Credit: Code Written by BHASKAR</p>
        </div>
        </body></html>